On June 30, 2015, the U.S. Food and Drug Administration implemented the Pregnancy and Lactation Labeling Rule (PLLR). The PLLR was issued to address the shortcomings of pregnancy and lactation information in prescription drug and biological product labeling. The new labeling format under PLLR is structured to better help providers communicate important information about the risks and benefits of taking a specific medication to their pregnant or breastfeeding patients.
Get full access to this article
View all access options for this article.
References
1.
CurtinSC, AbmaJC, VenturaSJ, HenshawSK. Pregnancy rates for U.S. women continue to drop. NCHS data brief, no 136. National Center for Health Statistics, 2013. Available at: https://www.cdc.gov/nchs/products/databriefs/db136.htm Accessed May26, 2017.
2.
MitchellAA, GilboaSM, WerlerMM, et al.Medication use during pregnancy, with particular focus on prescription drugs: 1976–2008. Am J Obstet Gynecol, 2011; 205:51.e1–51.e8.
3.
Center for Disease Control and Prevention. Breastfeeding among U.S. Children Born 2002–2013, CDC National Immunization Survey. Available at: www.cdc.gov/breastfeeding/data/nis_data/index.htm. Accessed April3, 2017.
Content and format of labeling for human prescription drug and biological products; requirements for pregnancy and lactation labeling. Final Rule. Federal Registry, 2014; 79:72063–72103. Available at: www.gpo.gov/fdsys/pkg/FR-2014-12-04/pdf/2014-28241.pdf. Accessed March23, 2017.
6.
PerniaS, DeMaagdG. The new pregnancy and lactation labeling rule. Pharm Ther, 2016; 41:713–715.
7.
WilmerE, ChaiS, KroumpouzousG. Drug Safety: pregnancy rating classifications and controversies. Clin Dermatol, 2016; 34:401–409.
8.
SahinL, NallaniSC, TassinariMS. Medication use in pregnancy and the pregnancy and lactation labeling rule. Clin Pharmacol Ther, 2016; 100:23–25.
9.
TassinariM, SahinL, YaoL. Brief Report: assessing Congenital Malformation Risk form Medications used in Pregnancy: the Contribution of NBDPS in Pregnancy Labeling of Prescription Drug Products. Birth Defects Res A, 2015; 103:718–720.
